An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab
Clinical trial NCT02754141 · COMPLETED
Trial details
- NCT number
- NCT02754141
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-21
- Primary completion
- 2021-10-12
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.